These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 17222367

  • 1. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
    Han YC, Zeng XX, Wang R, Zhao Y, Li BL, Song M.
    Ai Zheng; 2007 Jan; 26(1):48-53. PubMed ID: 17222367
    [Abstract] [Full Text] [Related]

  • 2. Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer.
    Wang R, Li ZQ, Han X, Li BL, Mi XY, Sun LM, Song M, Han YC, Zhao Y, Wang EH.
    APMIS; 2010 Dec; 118(12):909-17. PubMed ID: 21091771
    [Abstract] [Full Text] [Related]

  • 3. [Study of the relationship between early growth response gene 1 activity in p38 mitogen-activated protein kinase pathway and epirubicin resistance of human breast carcinoma cells].
    Xiao L, Hu JL, Cui W.
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):408-13. PubMed ID: 19781349
    [Abstract] [Full Text] [Related]

  • 4. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
    He X, Zheng Z, Li J, Ben Q, Liu J, Zhang J, Ji J, Yu B, Chen X, Su L, Zhou L, Liu B, Yuan Y.
    Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
    [Abstract] [Full Text] [Related]

  • 5. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
    Niiya M, Niiya K, Shibakura M, Asaumi N, Yoshida C, Shinagawa K, Teshima T, Ishimaru F, Ikeda K, Tanimoto M.
    Oncology; 2004 Mar; 67(3-4):310-9. PubMed ID: 15557793
    [Abstract] [Full Text] [Related]

  • 6. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
    Du J, Wang XF, Zhou QM, Zhang TL, Lu YY, Zhang H, Su SB.
    Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
    [Abstract] [Full Text] [Related]

  • 7. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A, Xue M, Jackson C, Smith RC.
    Int J Biochem Cell Biol; 2009 Aug; 41(8-9):1731-8. PubMed ID: 19433314
    [Abstract] [Full Text] [Related]

  • 8. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
    Lee KH, Hyun MS, Kim JR.
    Clin Exp Metastasis; 2003 Aug; 20(6):499-505. PubMed ID: 14598883
    [Abstract] [Full Text] [Related]

  • 9. Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients.
    Huang CY, Chang MC, Huang WY, Huang CT, Tang YC, Huang HD, Kuo KT, Chen CA, Cheng WF.
    Sci Rep; 2015 Jun 02; 5():10680. PubMed ID: 26033187
    [Abstract] [Full Text] [Related]

  • 10. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R, Philip S, Mahabeleshwar GH, Bulbule A, Kundu GC.
    IUBMB Life; 2005 Jun 02; 57(6):441-7. PubMed ID: 16012053
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo.
    Sun Y, Wang X, Zhou Q, Lu Y, Zhang H, Chen Q, Zhao M, Su S.
    Oncol Rep; 2015 Jan 02; 33(1):338-46. PubMed ID: 25370743
    [Abstract] [Full Text] [Related]

  • 12. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 02; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 13. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.
    Lee KH, Choi EY, Kim MK, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR.
    Exp Mol Med; 2006 Feb 28; 38(1):27-35. PubMed ID: 16520550
    [Abstract] [Full Text] [Related]

  • 14. (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells.
    Shin S, Kim MK, Jung W, Chong Y.
    Phytother Res; 2018 Oct 28; 32(10):2086-2096. PubMed ID: 30009577
    [Abstract] [Full Text] [Related]

  • 15. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion.
    Montero L, Nagamine Y.
    Cancer Res; 1999 Oct 15; 59(20):5286-93. PubMed ID: 10537311
    [Abstract] [Full Text] [Related]

  • 16. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
    Huang S, New L, Pan Z, Han J, Nemerow GR.
    J Biol Chem; 2000 Apr 21; 275(16):12266-72. PubMed ID: 10766865
    [Abstract] [Full Text] [Related]

  • 17. Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway.
    Wang XF, Zhou QM, Du J, Zhang H, Lu YY, Su SB.
    Anticancer Agents Med Chem; 2013 Jul 01; 13(6):923-31. PubMed ID: 23387975
    [Abstract] [Full Text] [Related]

  • 18. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
    Whitley BR, Beaulieu LM, Carter JC, Church FC.
    Gynecol Oncol; 2007 Feb 01; 104(2):470-9. PubMed ID: 17070899
    [Abstract] [Full Text] [Related]

  • 19. P38 MAPK pathway is involved in the urokinase plasminogen activator expression in human gastric SNU-638 cells.
    Shin BA, Yoo HG, Kim HS, Kim MH, Hwang YS, Chay KO, Lee KY, Ahn BW, Jung YD.
    Oncol Rep; 2003 Feb 01; 10(5):1467-71. PubMed ID: 12883725
    [Abstract] [Full Text] [Related]

  • 20. Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.
    Xue B, Wu W, Huang K, Xie T, Xu X, Zhang H, Qi C, Ge J, Yu Y.
    Mol Cell Biochem; 2013 Aug 01; 380(1-2):177-84. PubMed ID: 23615713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.